Rhythm Pharmaceuticals, Inc. (RYTM)

117.62 +12.85 (+12.26%) USD  |  NASDAQ  |  Dec 11, 16:00
117.67 +0.05 (+0.04%) After-Hours: 05:04
More

Rhythm Pharmaceuticals Total Expenses (% of Annual Revenues)

Total Expenses (% of Annual Revenues) Chart

View Total Expenses (% of Annual Revenues) for RYTM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (% of Annual Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Expenses (% of Annual Revenues) Range, Past 5 Years

View Total Expenses (% of Annual Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (% of Annual Revenues) Benchmarks

View Total Expenses (% of Annual Revenues) Benchmarks
Start Trial
Gilead Sciences, Inc. Upgrade
Terns Pharmaceuticals, Inc. --
Altimmune, Inc. Upgrade
Viking Therapeutics, Inc. --
Cidara Therapeutics, Inc. Upgrade